USE OF RECOMBINANT FACTOR VIIA FOR REFRACTORY BLEEDING IN VENTRICULAR ASSIST DEVICE PATIENTS: THE EDMONTON EXPERIENCE

被引：0
|
作者：
Nunes, A. J.
Hruczkowski, J.
Nahirniak, S.
MacArthur, R. G.
机构：
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2012年 / 28卷 / 05期
关键词：
D O I：
10.1016/j.cjca.2012.07.627
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S363 / S364
页数：2
相关论文
共 50 条
  • [31] Clinical experience with recombinant factor VIIa in patients with thrombocytopenia
    Kristensen, J
    Killander, A
    Hippe, E
    Helleberg, C
    Ellegard, J
    Holm, M
    Kutti, J
    Mellqvist, UH
    Johansson, JE
    Glazer, S
    Hedner, U
    HAEMOSTASIS, 1996, 26 : 159 - 164
  • [32] GASTROINTESTINAL BLEEDING EVENTS IN PATIENTS WITH A LEFT VENTRICULAR ASSIST DEVICE: A 10 YEAR EXPERIENCE
    Ranjan, Ravi
    Gunn, Melanie
    MacGowan, Guy
    Leeds, John
    GUT, 2021, 70 : A60 - A60
  • [33] Successful treatment of refractory bleeding after bridging from acute to chronic left ventricular assist device support with recombinant activated factor VII
    Flynn, JD
    Camp, PC
    Jahania, MS
    Ramaiah, C
    Akers, WS
    ASAIO JOURNAL, 2004, 50 (05) : 519 - 521
  • [34] A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions
    Mittal, S
    Watson, HG
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (04) : 355 - 363
  • [35] Successful use of recombinant factor VIIa in a bleeding patient with refractory thrombocytopenia undergoing chemotherapy for acute leukemia.
    Vidarsson, B
    Onundarson, PT
    BLOOD, 1999, 94 (10) : 239B - 239B
  • [36] The use of recombinant factor VIIa in life-threatening neonatal bleeding
    Papaioannou, G.
    Mitsiakos, G.
    Giougi, E.
    Papadakis, M.
    Topalidou, M.
    Karagianni, P.
    Nikolaidis, N.
    THROMBOSIS RESEARCH, 2007, 119 : S113 - S113
  • [37] Use of recombinant factor VIIa in treatment of bleeding episodes for patients with refractoriness to platelet transfusion therapy
    Sandilya, Vijay
    Gupta, Namita
    BLOOD, 2012, 120 (21)
  • [38] Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients
    Heisel, M
    Nagib, M
    Madsen, L
    Alshiekh, M
    Bendel, A
    PEDIATRIC BLOOD & CANCER, 2004, 43 (06) : 703 - 705
  • [39] Clinical use of recombinant factor VIIA: a single centre experience
    Greaves, P.
    Madhani, M.
    Hallam, S.
    McCallum, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 551 - 551
  • [40] Tumor necrosis factor-α inhibitor use for treatment of refractory cardiac sarcoidosis in a patient with left ventricular assist device: Adalimumab use in refractory sarcoidosis in a patient with left ventricular assist device
    Krishnan, Mrinalini
    Cupps, Thomas R.
    Sheikh, Farooq H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (12): : 1504 - 1505
12345